ELEVANCE HEALTH, INC. Available-for-sale Securities, Gross Unrealized Gain
ELEVANCE HEALTH, INC. (ELV) reported Available-for-sale Securities, Gross Unrealized Gain of $939.70 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2018-02-21
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2016-06-30 was $191.00M.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2016-03-31 was $908.00M, a 24.26% decline year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2015-12-31 was -$14.90M, a 201.36% decline year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2015-09-30 was -$65.20M.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for fiscal 2017 was $939.70M, a 25.53% increase from fiscal 2016.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for fiscal 2016 was $748.60M, a 8.15% decline from fiscal 2015.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for fiscal 2015 was $815.00M, a 29.43% decline from fiscal 2014.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross unrealized gain for fiscal 2014 was $1.15B, a 9.55% increase from fiscal 2013.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|---|
| 2017-12-31 | $939.70M 10-K · filed 2018-02-21 | |||
| 2016-12-31 | $748.60M 10-K · filed 2018-02-21 | |||
| 2016-06-30 | $191.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.10B 10-Q · filed 2016-07-27 | $1.08B derived: sum of 3 quarters · filed 2017-02-22 | $1.02B derived: sum of 4 quarters · filed 2017-02-22 |
| 2016-03-31 | $908.00M 10-Q · filed 2016-04-27 | $893.10M derived: sum of 2 quarters · filed 2017-02-22 | $827.90M derived: sum of 3 quarters · filed 2017-02-22 | $524.20M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-12-31 | -$14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$80.10M derived: sum of 2 quarters · filed 2017-02-22 | -$383.80M derived: sum of 3 quarters · filed 2017-02-22 | $815.00M 10-K · filed 2017-02-22 |
| 2015-09-30 | -$65.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | -$368.90M derived: sum of 2 quarters · filed 2015-10-28 | $829.90M 10-Q · filed 2015-10-28 | $844.60M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-06-30 | -$303.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $895.10M 10-Q · filed 2015-07-29 | $909.80M derived: sum of 3 quarters · filed 2016-02-19 | $765.20M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-03-31 | $1.20B 10-Q · filed 2015-04-29 | $1.21B derived: sum of 2 quarters · filed 2016-02-19 | $1.07B derived: sum of 3 quarters · filed 2016-02-19 | $1.20B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$129.90M derived: sum of 2 quarters · filed 2016-02-19 | -$1.60M derived: sum of 3 quarters · filed 2016-02-19 | $1.15B 10-K · filed 2016-02-19 |
| 2014-09-30 | -$144.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$16.30M derived: sum of 2 quarters · filed 2014-10-29 | $1.14B 10-Q · filed 2014-10-29 | $1.19B derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-06-30 | $128.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $1.28B 10-Q · filed 2014-07-30 | $1.34B derived: sum of 3 quarters · filed 2015-04-29 | $1.32B derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-03-31 | $1.16B 10-Q · filed 2015-04-29 | $1.21B derived: sum of 2 quarters · filed 2015-04-29 | $1.19B derived: sum of 3 quarters · filed 2015-04-29 | $886.40M derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-12-31 | $51.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $37.80M derived: sum of 2 quarters · filed 2015-02-24 | -$270.10M derived: sum of 3 quarters · filed 2015-02-24 | $1.05B 10-K · filed 2015-02-24 |
| 2013-09-30 | -$13.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$321.30M derived: sum of 2 quarters · filed 2014-10-29 | $1.00B 10-Q · filed 2014-10-29 | |
| 2013-06-30 | -$307.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $1.02B 10-Q · filed 2014-07-30 | ||
| 2013-03-31 | $1.32B 10-Q · filed 2014-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |